US FDA has the unenviable task of picking the most important adverse events to track once coronavirus vaccinations begin; CDC's list will need to be winnowed to 10-20 to make the surveillance feasible, and which AEs make the cut may be informed by the vaccine trials, as well as clinical experience with COVID infections.
The US Food and Drug Administration has the unenviable task of picking the most important adverse events to track once coronavirus vaccination begins.
Agency officials expect to monitor adverse event reports in near real-time once a coronavirus vaccine becomes available. Data is expected...